Ramona Reichenbach

Managed Access & Medical Policy Head Novartis AG

Ramona Reichenbach is Head of Managed Access & Medical Policy at Novartis, where she leads enterprise-wide strategy, governance, and global standards for Managed Access and Post-Trial Access programmes. With over 20 years in global drug development, she specialises in designing scalable frameworks, aligning cross-functional stakeholders, and shaping policy to enable equitable access across diverse healthcare systems. A recognised thought leader in the field, Ramona actively contributes to industry collaboration, publications, and global forums to advance harmonisation and improve how access programmes are delivered worldwide.

Seminars

Tuesday 20th October 2026
Shaping the Future of Early Access in Europe Understanding the Impact of New EU Pharmaceutical Legislation
2:00 pm
  • Exploring what the new EU pharmaceutical legislation introduces for early and compassionate access pathways
  • Understanding the opportunities and challenges this creates for industry regulators and patients across Europe
  • Highlighting how stakeholders can collaborate to maximise the impact of the new framework
  • Setting the foundation for broader discussion on how early access can evolve under this changing regulatory landscape 
Wednesday 21st October 2026
The Communication Challenge: Navigating awareness & HCP support in EAPs
12:30 pm
  • When silence becomes an access barrier: considering whether limited awareness of access routes can unintentionally favour well-connected centres, established KOL networks or more vocal patient communities
  • Responsible visibility, not promotion: exploring how factual, balanced and appropriately governed information can support equitable awareness without creating inappropriate demand, expectation or pressure
  • Supporting fair, physician-led access: reflecting on how non-promotional communication can help HCPs understand when an access route may be relevant, while preserving clinical independence, patient safety and programme sustainability
Wednesday 21st October 2026
ia4ma: Achieving Global Impact Through a Non-Profit, Independent Association
2:15 pm
  • Establishing a shared vision and foundation for Managed Access, aligning on ethical principles and industry standards to reduce fragmentation and enable sustainable global pathways
  • Delivering value for patients, industry and stakeholders by accelerating equitable access, improving operational efficiency, and enabling meaningful peer and regulatory exchange
  • Driving system level impact beyond individual programs by shaping policy, fostering multi stakeholder collaboration, and strengthening global trust in Managed Access
Ramona Reichenbach - 5th Operationalise Early Access Programmes Europe